A phase II, open-label, multi-dose study of [89Zr]Zr-Df-IAB22M2C (CD8 cell PET tracer) PET/CT in patients with selected advanced or metastatic solid malignancies scheduled to receive standard of care immunotherapy, as single agent or in combination Meeting Abstract
| Authors: | Margolin, K. A.; Korn, R.; Farwell, M.; Postow, M. A.; Hays, D.; Wilson, I. A.; Le, W. H. |
| Abstract Title: | A phase II, open-label, multi-dose study of [89Zr]Zr-Df-IAB22M2C (CD8 cell PET tracer) PET/CT in patients with selected advanced or metastatic solid malignancies scheduled to receive standard of care immunotherapy, as single agent or in combination |
| Meeting Title: | ESMO Congress 2021 |
| Journal Title: | Annals of Oncology |
| Volume: | 32 |
| Issue: | Suppl. 5 |
| Meeting Dates: | 2021 Sep 16-21 |
| Meeting Location: | Virtual |
| ISSN: | 0923-7534 |
| Publisher: | Oxford University Press |
| Date Published: | 2021-09-01 |
| Start Page: | S930 |
| Language: | English |
| ACCESSION: | WOS:000700527702167 |
| DOI: | 10.1016/j.annonc.2021.08.791 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract #1150TiP -- Source: Wos |
